(AME) Ametek - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0311001004
Instruments, Sensors, Connectors, Motors, Thermal Management
Dividends
| Dividend Yield | 0.63% |
| Yield on Cost 5y | 1.08% |
| Yield CAGR 5y | 11.68% |
| Payout Consistency | 92.0% |
| Payout Ratio | 17.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.7% |
| Value at Risk 5%th | 30.7% |
| Relative Tail Risk | -9.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -10.06 |
| CAGR/Max DD | 0.51 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.446 |
| Beta | 0.791 |
| Beta Downside | 0.858 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.04% |
| Mean DD | 5.57% |
| Median DD | 5.39% |
Description: AME Ametek December 03, 2025
AMETEK (NYSE:AME) operates two primary segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). EIG supplies advanced measurement and control hardware across aerospace, power, industrial, oil & gas, semiconductor, and food-and-beverage markets, including sensors, UPS systems, and precision test equipment. EMG focuses on engineered medical components, high-performance specialty metals, thermal-management hardware, and motion-control products, while also running an aviation MRO network.
Key recent metrics (FY 2023): revenue of roughly $6.5 billion, operating margin near 12 %, and a 4 % YoY increase in aerospace sensor sales-driven by rising defense spending and commercial aircraft fleet upgrades. The segment’s growth is also supported by robust demand for industrial automation, as global capex on robotics and control systems is projected to expand at a 9 % CAGR through 2028.
Given AMETEK’s diversified exposure to high-growth end-markets and its historically stable cash-flow profile, analysts often watch its free-cash-flow conversion (≈ 80 % of earnings) as a bellwether for dividend sustainability. For a deeper quantitative breakdown, see the ValueRay analysis of AME.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.47b TTM) > 0 and > 6% of Revenue (6% = 429.9m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -1.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.75% (prev 11.10%; Δ -5.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.77b > Net Income 1.47b (YES >=105%, WARN >=100%) |
| Net Debt (2.31b) to EBITDA (2.16b) ratio: 1.07 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (231.7m) change vs 12m ago -0.24% (target <= -2.0% for YES) |
| Gross Margin 36.18% (prev 35.41%; Δ 0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.30% (prev 46.79%; Δ -0.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 23.01 (EBITDA TTM 2.16b / Interest Expense TTM 80.4m) >= 6 (WARN >= 3) |
Altman Z'' 5.51
| (A) 0.03 = (Total Current Assets 3.06b - Total Current Liabilities 2.65b) / Total Assets 16.18b |
| (B) 0.74 = Retained Earnings (Balance) 11.92b / Total Assets 16.18b |
| (C) 0.12 = EBIT TTM 1.85b / Avg Total Assets 15.47b |
| (D) 2.03 = Book Value of Equity 11.49b / Total Liabilities 5.66b |
| Total Rating: 5.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.57
| 1. Piotroski 6.50pt |
| 2. FCF Yield 3.40% |
| 3. FCF Margin 22.93% |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda 1.07 |
| 6. ROIC - WACC (= 4.06)% |
| 7. RoE 14.49% |
| 8. Rev. Trend 94.84% |
| 9. EPS Trend 82.22% |
What is the price of AME shares?
As of December 10, 2025, the stock is trading at USD 195.97 with a total of 1,005,975 shares traded.
Over the past week, the price has changed by -0.51%, over one month by -0.88%, over three months by +4.86% and over the past year by +3.90%.
Over the past week, the price has changed by -0.51%, over one month by -0.88%, over three months by +4.86% and over the past year by +3.90%.
Is AME a buy, sell or hold?
Ametek has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy AME.
- Strong Buy: 10
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the AME price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 220.2 | 12.4% |
| Analysts Target Price | 220.2 | 12.4% |
| ValueRay Target Price | 214.7 | 9.6% |
AME Fundamental Data Overview December 10, 2025
Market Cap USD = 46.02b (46.02b USD * 1.0 USD.USD)
P/E Trailing = 31.429
P/E Forward = 26.8817
P/S = 6.4235
P/B = 4.3575
P/EG = 2.6891
Beta = 1.047
Revenue TTM = 7.16b USD
EBIT TTM = 1.85b USD
EBITDA TTM = 2.16b USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 1.10b USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.31b USD (from netDebt column, last quarter)
Enterprise Value = 48.33b USD (46.02b + Debt 2.75b - CCE 439.2m)
Interest Coverage Ratio = 23.01 (Ebit TTM 1.85b / Interest Expense TTM 80.4m)
FCF Yield = 3.40% (FCF TTM 1.64b / Enterprise Value 48.33b)
FCF Margin = 22.93% (FCF TTM 1.64b / Revenue TTM 7.16b)
Net Margin = 20.50% (Net Income TTM 1.47b / Revenue TTM 7.16b)
Gross Margin = 36.18% ((Revenue TTM 7.16b - Cost of Revenue TTM 4.57b) / Revenue TTM)
Gross Margin QoQ = 36.25% (prev 35.76%)
Tobins Q-Ratio = 2.99 (Enterprise Value 48.33b / Total Assets 16.18b)
Interest Expense / Debt = 0.82% (Interest Expense 22.5m / Debt 2.75b)
Taxrate = 17.09% (76.5m / 448.0m)
NOPAT = 1.53b (EBIT 1.85b * (1 - 17.09%))
Current Ratio = 1.16 (Total Current Assets 3.06b / Total Current Liabilities 2.65b)
Debt / Equity = 0.26 (Debt 2.75b / totalStockholderEquity, last quarter 10.53b)
Debt / EBITDA = 1.07 (Net Debt 2.31b / EBITDA 2.16b)
Debt / FCF = 1.40 (Net Debt 2.31b / FCF TTM 1.64b)
Total Stockholder Equity = 10.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.08% (Net Income 1.47b / Total Assets 16.18b)
RoE = 14.49% (Net Income TTM 1.47b / Total Stockholder Equity 10.14b)
RoCE = 15.99% (EBIT 1.85b / Capital Employed (Equity 10.14b + L.T.Debt 1.43b))
RoIC = 12.53% (NOPAT 1.53b / Invested Capital 12.24b)
WACC = 8.47% (E(46.02b)/V(48.77b) * Re(8.93%) + D(2.75b)/V(48.77b) * Rd(0.82%) * (1-Tc(0.17)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 78.37% ; FCFE base≈1.66b ; Y1≈2.01b ; Y5≈3.31b
Fair Price DCF = 207.8 (DCF Value 47.84b / Shares Outstanding 230.2m; 5y FCF grow 22.85% → 3.0% )
EPS Correlation: 82.22 | EPS CAGR: 8.96% | SUE: 4.0 | # QB: 16
Revenue Correlation: 94.84 | Revenue CAGR: 6.33% | SUE: 2.21 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.89 | Chg30d=+0.001 | Revisions Net=+5 | Analysts=11
EPS next Year (2026-12-31): EPS=7.96 | Chg30d=+0.012 | Revisions Net=+16 | Growth EPS=+8.4% | Growth Revenue=+7.4%
P/E Trailing = 31.429
P/E Forward = 26.8817
P/S = 6.4235
P/B = 4.3575
P/EG = 2.6891
Beta = 1.047
Revenue TTM = 7.16b USD
EBIT TTM = 1.85b USD
EBITDA TTM = 2.16b USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 1.10b USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.31b USD (from netDebt column, last quarter)
Enterprise Value = 48.33b USD (46.02b + Debt 2.75b - CCE 439.2m)
Interest Coverage Ratio = 23.01 (Ebit TTM 1.85b / Interest Expense TTM 80.4m)
FCF Yield = 3.40% (FCF TTM 1.64b / Enterprise Value 48.33b)
FCF Margin = 22.93% (FCF TTM 1.64b / Revenue TTM 7.16b)
Net Margin = 20.50% (Net Income TTM 1.47b / Revenue TTM 7.16b)
Gross Margin = 36.18% ((Revenue TTM 7.16b - Cost of Revenue TTM 4.57b) / Revenue TTM)
Gross Margin QoQ = 36.25% (prev 35.76%)
Tobins Q-Ratio = 2.99 (Enterprise Value 48.33b / Total Assets 16.18b)
Interest Expense / Debt = 0.82% (Interest Expense 22.5m / Debt 2.75b)
Taxrate = 17.09% (76.5m / 448.0m)
NOPAT = 1.53b (EBIT 1.85b * (1 - 17.09%))
Current Ratio = 1.16 (Total Current Assets 3.06b / Total Current Liabilities 2.65b)
Debt / Equity = 0.26 (Debt 2.75b / totalStockholderEquity, last quarter 10.53b)
Debt / EBITDA = 1.07 (Net Debt 2.31b / EBITDA 2.16b)
Debt / FCF = 1.40 (Net Debt 2.31b / FCF TTM 1.64b)
Total Stockholder Equity = 10.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.08% (Net Income 1.47b / Total Assets 16.18b)
RoE = 14.49% (Net Income TTM 1.47b / Total Stockholder Equity 10.14b)
RoCE = 15.99% (EBIT 1.85b / Capital Employed (Equity 10.14b + L.T.Debt 1.43b))
RoIC = 12.53% (NOPAT 1.53b / Invested Capital 12.24b)
WACC = 8.47% (E(46.02b)/V(48.77b) * Re(8.93%) + D(2.75b)/V(48.77b) * Rd(0.82%) * (1-Tc(0.17)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 78.37% ; FCFE base≈1.66b ; Y1≈2.01b ; Y5≈3.31b
Fair Price DCF = 207.8 (DCF Value 47.84b / Shares Outstanding 230.2m; 5y FCF grow 22.85% → 3.0% )
EPS Correlation: 82.22 | EPS CAGR: 8.96% | SUE: 4.0 | # QB: 16
Revenue Correlation: 94.84 | Revenue CAGR: 6.33% | SUE: 2.21 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.89 | Chg30d=+0.001 | Revisions Net=+5 | Analysts=11
EPS next Year (2026-12-31): EPS=7.96 | Chg30d=+0.012 | Revisions Net=+16 | Growth EPS=+8.4% | Growth Revenue=+7.4%
Additional Sources for AME Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle